Sigma-1 Receptor Agonist TS-157 Improves Motor Functional Recovery by Promoting Neurite Outgrowth and pERK in Rats with Focal Cerebral Ischemia.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
24 Feb 2021
Historique:
received: 13 01 2021
revised: 20 02 2021
accepted: 21 02 2021
entrez: 6 3 2021
pubmed: 7 3 2021
medline: 10 4 2021
Statut: epublish

Résumé

Sigma-1 (σ-1) receptor agonists are considered as potential treatment for stroke. TS-157 is an alkoxyisoxazole-based σ-1 receptor agonist previously discovered in our group. The present study describes TS-157 profile in a battery of tests for cerebral ischemia. Initial evaluation demonstrated the compound's safety profile and blood-brain barrier permeability, as well as its ability to induce neurite outgrowth in vitro. The neurite outgrowth was shown to be mediated via σ-1 receptor agonism and involves upregulation of ERK phosphorylation (pERK). In particular, TS-157 also significantly accelerated the recovery of motor function in rats with transient middle cerebral artery occlusion (tMCAO). Overall, the results herein support the notion that σ-1 receptor agonists are potential therapeutics for stroke and further animal efficacy studies are warranted.

Identifiants

pubmed: 33668340
pii: molecules26051212
doi: 10.3390/molecules26051212
pmc: PMC7956808
pii:
doi:

Substances chimiques

Oxazoles 0
Receptors, sigma 0
Extracellular Signal-Regulated MAP Kinases EC 2.7.11.24

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Natural Science Foundation of China
ID : 81402780, 81973512

Références

Neurosci Lett. 2014 Jan 24;559:174-8
pubmed: 24334165
J Med Chem. 2012 Jan 26;55(2):812-23
pubmed: 22148173
PLoS One. 2013 Apr 18;8(4):e61245
pubmed: 23637801
Exp Neurol. 2020 May;327:113245
pubmed: 32067950
Brain Res Bull. 2011 May 30;85(3-4):219-24
pubmed: 21453760
J Pharm Sci. 2009 Jun;98(6):1980-91
pubmed: 18837012
BMC Biochem. 2015 Apr 30;16:11
pubmed: 25924612
Neurosci Lett. 2017 Mar 6;642:86-90
pubmed: 28163081
Brain Behav Immun. 2015 Nov;50:298-313
pubmed: 26188187
Nat Rev Neurosci. 2009 Mar;10(3):235-41
pubmed: 19229242
J Pharmacol Exp Ther. 2000 Jun;293(3):788-98
pubmed: 10869377
Oxid Med Cell Longev. 2018 Jan 31;2018:3804979
pubmed: 29770166
Pharmacol Ther. 2009 Nov;124(2):195-206
pubmed: 19619582
Nat Chem Biol. 2008 May;4(5):313-21
pubmed: 18408713
J Pharmacol Exp Ther. 1976 Jun;197(3):517-32
pubmed: 945347
Trends Neurosci. 2012 Dec;35(12):762-71
pubmed: 23102998
J Pharmacol Exp Ther. 2010 Mar;332(3):1054-63
pubmed: 19940104
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8196-9
pubmed: 10393971
Brain Res Bull. 2016 Mar;121:75-83
pubmed: 26772628
Trends Pharmacol Sci. 2010 Dec;31(12):557-66
pubmed: 20869780
J Pharmacol Exp Ther. 2010 Feb;332(2):388-97
pubmed: 19855099
ACS Chem Neurosci. 2016 Jun 15;7(6):767-75
pubmed: 26991242
PLoS One. 2013 Oct 18;8(10):e76941
pubmed: 24204710
ACS Med Chem Lett. 2012 Dec 13;3(12):1054-1058
pubmed: 23641311
Neuron. 2001 Sep 27;31(6):957-71
pubmed: 11580896
J Physiol. 2007 Jan 1;578(Pt 1):143-57
pubmed: 17068104
Eur J Med Chem. 2003 Mar;38(3):223-32
pubmed: 12667689
Neuron. 2002 Apr 25;34(3):399-410
pubmed: 11988171
Neurochem Res. 2017 Dec;42(12):3515-3524
pubmed: 28993995
J Med Chem. 2016 Jul 14;59(13):6329-43
pubmed: 27309376
J Cereb Blood Flow Metab. 1998 Feb;18(2):196-205
pubmed: 9469163
Brain. 2011 Mar;134(Pt 3):732-46
pubmed: 21278085
Interv Neurol. 2013 Sep;1(3-4):185-99
pubmed: 25187778
Nature. 2016 Apr 28;532(7600):527-30
pubmed: 27042935
PLoS One. 2013 Oct 08;8(10):e75760
pubmed: 24116072
Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22468-73
pubmed: 20018732
Neurobiol Dis. 2014 Feb;62:354-64
pubmed: 24141021
Cell. 2007 Nov 2;131(3):596-610
pubmed: 17981125
Neuroscience. 2000;97(1):155-70
pubmed: 10771347
J Pharm Sci. 1999 Aug;88(8):815-21
pubmed: 10430548
Cell. 2013 Jan 17;152(1-2):236-47
pubmed: 23332758

Auteurs

Jun-Jie Shi (JJ)

Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China.

Qi-Hui Jiang (QH)

New Drug Screening Center, Jiangsu Center for Pharmacodynamics Research and Evaluation, Institute of Pharmaceutical Sciences, China Pharmaceutical University, Nanjing 210009, China.

Tian-Ning Zhang (TN)

New Drug Screening Center, Jiangsu Center for Pharmacodynamics Research and Evaluation, Institute of Pharmaceutical Sciences, China Pharmaceutical University, Nanjing 210009, China.

Hao Sun (H)

Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China.

Wen-Wen Shi (WW)

Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China.

Hendra Gunosewoyo (H)

School of Pharmacy and Biomedical Sciences, Faculty of Health Sciences, Curtin University, Bentley, Perth, WA 6102, Australia.

Fan Yang (F)

Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China.

Jie Tang (J)

Shanghai Key Laboratory of Green Chemistry and Chemical Process, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China.

Tao Pang (T)

New Drug Screening Center, Jiangsu Center for Pharmacodynamics Research and Evaluation, Institute of Pharmaceutical Sciences, China Pharmaceutical University, Nanjing 210009, China.

Li-Fang Yu (LF)

Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai 200062, China.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH